Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer.

Journal of translational medicine - 10 Jun 2024

Zhou Siyu, Tao Baian, Guo Yujie, Gu Jichun, Li Hengchao, Zou Caifeng, Tang Sichong, Jiang Shuheng, Fu Deliang, Li Ji

Abstract excerpt

BACKGROUND: Deciphering the role of plasma proteins in pancreatic cancer (PC) susceptibility can aid in identifying novel targets for diagnosis and treatment. METHODS: We examined the relationship between genetically determined levels of plasma proteins and PC through a systemic proteome-wide Mendelian randomization (MR) analysis utilizing cis-pQTLs from multiple centers. Rigorous sensitivity analyses,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Proteins
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mendelian Randomization Analysis

Share to Molecular Targeted Therapy

Share to Multiomics

Share to Pancreatic Neoplasms

Share to Proteomics

Share to Reproducibility of Results

Source

Open in PubMed Open full text

Identifiers

PMID: 38858729
DOI: 10.1186/s12967-024-05363-9
PMCID: PMC11165868

Genes

PC
ABO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer.PMID 38858729Read ↗

Proteome-Wide Mendelian Randomization Identifies Causal Links Between Blood Proteins and Acute Pancreatitis.Semantic proximity Read ↗

Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers.Semantic proximity Read ↗

Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization.Semantic proximity Read ↗

Assessing the Causal Impact of the Circulating Proteome on Susceptibility to Gastrointestinal Cancer-Associated CharacteristicsSemantic proximity Read ↗

Exploring Potential Drug Targets for Pancreatic Cancer Based on Mendelian RandomizationSemantic proximity Read ↗

Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerSemantic proximity Read ↗

Genetically predicted blood metabolites mediate the association between circulating immune cells and pancreatic cancer: A Mendelian randomization study.Semantic proximity Read ↗

Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: metabolite genomewide association study based on the KCPS-II cohortSemantic proximity Read ↗

Genomic atlas of 7,000 plasma proteins and their associations with diseases and traits in East Asian populationsSemantic proximity Read ↗

Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Identification of biomarkers and potential therapeutic targets for pancreatic cancer by proteomic analysis in two prospective cohortsSemantic proximity Read ↗

A multi-omics analysis of pancreatitis: bridging familial genetics and disease progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.